BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22414550)

  • 1. Alzheimer's disease: genetic polymorphisms and rate of decline.
    Schmidt C; Wolff M; von Ahsen N; Zerr I
    Dement Geriatr Cogn Disord; 2012; 33(2-3):84-9. PubMed ID: 22414550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CR1 is potentially associated with rate of decline in sporadic Alzheimer's disease.
    Schmidt C; Wolff M; von Ahsen N; Lange K; Friede T; Zerr I
    J Clin Neurosci; 2014 Oct; 21(10):1705-8. PubMed ID: 24998857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implication of common and disease specific variants in CLU, CR1, and PICALM.
    Ferrari R; Moreno JH; Minhajuddin AT; O'Bryant SE; Reisch JS; Barber RC; Momeni P
    Neurobiol Aging; 2012 Aug; 33(8):1846.e7-18. PubMed ID: 22402018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Most rapid cognitive decline in APOE epsilon4 negative Alzheimer's disease with early onset.
    van der Vlies AE; Koedam EL; Pijnenburg YA; Twisk JW; Scheltens P; van der Flier WM
    Psychol Med; 2009 Nov; 39(11):1907-11. PubMed ID: 19335933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of a genetic variant at PICALM in Alzheimer’s disease patients and centenarians.
    Piaceri I; Bagnoli S; Lucenteforte E; Mancuso M; Tedde A; Siciliano G; Piacentini S; Bracco L; Sorbi S; Nacmias B
    J Alzheimers Dis; 2011; 24(3):409-13. PubMed ID: 21297266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between PICALM rs3851179 polymorphism and Alzheimer's disease in Chinese population and APOEε4-negative subgroup.
    Liu G; Zhang L; Feng R; Liao M; Jiang Y; Chen Z; Zhao B; Li K
    Neurobiol Aging; 2013 Apr; 34(4):1310.e9-10. PubMed ID: 23040034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study.
    Sweet RA; Seltman H; Emanuel JE; Lopez OL; Becker JT; Bis JC; Weamer EA; DeMichele-Sweet MA; Kuller LH
    Am J Psychiatry; 2012 Sep; 169(9):954-62. PubMed ID: 22952074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic analysis of candidate genes for Alzheimer's disease in a French, genome-wide association study.
    Laumet G; Chouraki V; Grenier-Boley B; Legry V; Heath S; Zelenika D; Fievet N; Hannequin D; Delepine M; Pasquier F; Hanon O; Brice A; Epelbaum J; Berr C; Dartigues JF; Tzourio C; Campion D; Lathrop M; Bertram L; Amouyel P; Lambert JC
    J Alzheimers Dis; 2010; 20(4):1181-8. PubMed ID: 20413850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. rs3851179 Polymorphism at 5' to the PICALM Gene is Associated with Alzheimer and Parkinson Diseases in Brazilian Population.
    Santos-Rebouças CB; Gonçalves AP; Dos Santos JM; Abdala BB; Motta LB; Laks J; de Borges MB; de Rosso ALZ; Pereira JS; Nicaretta DH; Pimentel MMG
    Neuromolecular Med; 2017 Sep; 19(2-3):293-299. PubMed ID: 28567584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.
    Pedraza O; Allen M; Jennette K; Carrasquillo M; Crook J; Serie D; Pankratz VS; Palusak R; Nguyen T; Malphrus K; Ma L; Bisceglio G; Roberts RO; Lucas JA; Ivnik RJ; Smith GE; Graff-Radford NR; Petersen RC; Younkin SG; Ertekin-Taner N
    Alzheimers Dement; 2014 Mar; 10(2):205-13. PubMed ID: 23643458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics of Alzheimer's disease: new evidences for an old hypothesis?
    Lambert JC; Amouyel P
    Curr Opin Genet Dev; 2011 Jun; 21(3):295-301. PubMed ID: 21371880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype patterns at PICALM, CR1, BIN1, CLU, and APOE genes are associated with episodic memory.
    Barral S; Bird T; Goate A; Farlow MR; Diaz-Arrastia R; Bennett DA; Graff-Radford N; Boeve BF; Sweet RA; Stern Y; Wilson RS; Foroud T; Ott J; Mayeux R;
    Neurology; 2012 May; 78(19):1464-71. PubMed ID: 22539578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.
    Helisalmi S; Väkevä A; Hiltunen M; Soininen H
    Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of CLU and PICALM polymorphisms on AD risk: A study from south India.
    Shankarappa BM; Kota LN; Purushottam M; Nagpal K; Mukherjee O; Viswanath B; Varghese M; Bharath S; Jain S
    Asian J Psychiatr; 2017 Jun; 27():7-11. PubMed ID: 28558900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LACK OF ASSOCIATIONS BETWEEN CLU AND PICALM GENE POLYMORPHISMS AND ALZHEIMER'S DISEASE IN A TURKISH POPULATION.
    Sen A; Arslan M; Erdal ME; Ay OI; Yilmaz SG; Kurt E; Arpaci B
    Ideggyogy Sz; 2015 Mar; 68(3-4):113-20. PubMed ID: 26434199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association between CALHM1, 2, and 3 polymorphisms and Alzheimer's disease in a Japanese population.
    Shibata N; Kuerban B; Komatsu M; Ohnuma T; Baba H; Arai H
    J Alzheimers Dis; 2010; 20(2):417-21. PubMed ID: 20164573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An APOE haplotype associated with decreased ε4 expression increases the risk of late onset Alzheimer's disease.
    Lescai F; Chiamenti AM; Codemo A; Pirazzini C; D'Agostino G; Ruaro C; Ghidoni R; Benussi L; Galimberti D; Esposito F; Marchegiani F; Cardelli M; Olivieri F; Nacmias B; Sorbi S; Tagliavini F; Albani D; Martinelli Boneschi F; Binetti G; Santoro A; Forloni G; Scarpini E; Crepaldi G; Gabelli C; Franceschi C
    J Alzheimers Dis; 2011; 24(2):235-45. PubMed ID: 21263195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations.
    Lambert JC; Zelenika D; Hiltunen M; Chouraki V; Combarros O; Bullido MJ; Tognoni G; Fiévet N; Boland A; Arosio B; Coto E; Del Zompo M; Mateo I; Frank-Garcia A; Helisalmi S; Porcellini E; Pilotto A; Forti P; Ferri R; Delepine M; Scarpini E; Siciliano G; Solfrizzi V; Sorbi S; Spalletta G; Ravaglia G; Valdivieso F; Alvarez V; Bosco P; Mancuso M; Panza F; Nacmias B; Bossù P; Piccardi P; Annoni G; Seripa D; Galimberti D; Licastro F; Lathrop M; Soininen H; Amouyel P
    Neurobiol Aging; 2011 Apr; 32(4):756.e11-5. PubMed ID: 21220176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
    Belbin O; Beaumont H; Warden D; Smith AD; Kalsheker N; Morgan K
    Neurobiol Aging; 2009 Dec; 30(12):1992-9. PubMed ID: 18403054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.